BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27389057)

  • 21. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
    Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
    Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
    Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
    Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
    Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
    Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma.
    Brodtkorb M; Lingjærde OC; Huse K; Trøen G; Hystad M; Hilden VI; Myklebust JH; Leich E; Rosenwald A; Delabie J; Holte H; Smeland EB
    Blood; 2014 Feb; 123(7):1051-4. PubMed ID: 24357726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor suppressors in follicular lymphoma.
    Graham C; LeBrun DP
    Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of FL into DLBCL with a PMBL gene expression signature.
    Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
    Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
    Ouansafi I; He B; Fraser C; Nie K; Mathew S; Bhanji R; Hoda R; Arabadjief M; Knowles D; Cerutti A; Orazi A; Tam W
    Am J Clin Pathol; 2010 Dec; 134(6):972-81. PubMed ID: 21088162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The many layers of epigenetic dysfunction in B-cell lymphomas.
    Jiang Y; Dominguez PM; Melnick AM
    Curr Opin Hematol; 2016 Jul; 23(4):377-84. PubMed ID: 27055146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin modifying gene mutations in follicular lymphoma.
    Green MR
    Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
    Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
    Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Boonstra R; Bosga-Bouwer A; Mastik M; Haralambieva E; Conradie J; van den Berg E; van den Berg A; Poppema S
    Hum Pathol; 2003 Sep; 34(9):915-23. PubMed ID: 14562288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
    Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
    Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
    Green MR; Gentles AJ; Nair RV; Irish JM; Kihira S; Liu CL; Kela I; Hopmans ES; Myklebust JH; Ji H; Plevritis SK; Levy R; Alizadeh AA
    Blood; 2013 Feb; 121(9):1604-11. PubMed ID: 23297126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
    Matolcsy A; Casali P; Warnke RA; Knowles DM
    Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of the frequently amplified 2p15-p16.1 locus reveals PAPOLG as a potential proto-oncogene in follicular and transformed follicular lymphoma.
    Kurşun D; Küçük C
    Turk J Biol; 2019; 43():124-132. PubMed ID: 31410080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
    Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
    Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MYC expression and translocation analyses in low-grade and transformed follicular lymphoma.
    Aukema SM; van Pel R; Nagel I; Bens S; Siebert R; Rosati S; van den Berg E; Bosga-Bouwer AG; Kibbelaar RE; Hoogendoorn M; van Imhoff GW; Kluin-Nelemans HC; Kluin PM; Nijland M
    Histopathology; 2017 Dec; 71(6):960-971. PubMed ID: 28730642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic evolution of
    Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
    Haematologica; 2021 Oct; 106(10):2673-2681. PubMed ID: 32855278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
    Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
    Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.